2-50346870-GCGCCGCCGCCGCCGCCGC-GCGCCGCCGC

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The ENST00000342183.9(NRXN1):​c.71_79delGCGGCGGCG​(p.Gly24_Gly26del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.000902 in 1,366,786 control chromosomes in the GnomAD database, including 37 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0028 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00066 ( 37 hom. )

Consequence

NRXN1
ENST00000342183.9 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.96

Publications

0 publications found
Variant links:
Genes affected
NRXN1 (HGNC:8008): (neurexin 1) This gene encodes a single-pass type I membrane protein that belongs to the neurexin family. Neurexins are cell-surface receptors that bind neuroligins to form Ca(2+)-dependent neurexin/neuroligin complexes at synapses in the central nervous system. This complex is required for efficient neurotransmission and is involved in the formation of synaptic contacts. Three members of this gene family have been studied in detail and are estimated to generate over 3,000 variants through the use of two alternative promoters (alpha and beta) and extensive alternative splicing in each family member. Recently, a third promoter (gamma) was identified for this gene in the 3' region. Mutations in this gene are associated with Pitt-Hopkins-like syndrome-2 and may contribute to susceptibility to schizophrenia. [provided by RefSeq, Aug 2016]
NRXN1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • chromosome 2p16.3 deletion syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Pitt-Hopkins-like syndrome 2
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autism
    Inheritance: AD Classification: MODERATE Submitted by: G2P
  • schizophrenia
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in ENST00000342183.9
BP6
Variant 2-50346870-GCGCCGCCGC-G is Benign according to our data. Variant chr2-50346870-GCGCCGCCGC-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 281242.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00282 (425/150480) while in subpopulation AFR AF = 0.00855 (353/41300). AF 95% confidence interval is 0.00781. There are 0 homozygotes in GnomAd4. There are 206 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 37 AR,AD,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NRXN1NM_001330078.2 linkc.3365-109909_3365-109901delGCGGCGGCG intron_variant Intron 17 of 22 ENST00000401669.7 NP_001317007.1 E7ERL8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NRXN1ENST00000401669.7 linkc.3365-109909_3365-109901delGCGGCGGCG intron_variant Intron 17 of 22 5 NM_001330078.2 ENSP00000385017.2 E7ERL8

Frequencies

GnomAD3 genomes
AF:
0.00280
AC:
421
AN:
150380
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00847
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00232
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000393
Gnomad SAS
AF:
0.00187
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000341
Gnomad OTH
AF:
0.00145
GnomAD2 exomes
AF:
0.00148
AC:
111
AN:
74950
AF XY:
0.00160
show subpopulations
Gnomad AFR exome
AF:
0.00305
Gnomad AMR exome
AF:
0.00646
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00466
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000290
Gnomad OTH exome
AF:
0.00108
GnomAD4 exome
AF:
0.000664
AC:
808
AN:
1216306
Hom.:
37
AF XY:
0.000748
AC XY:
445
AN XY:
594994
show subpopulations
African (AFR)
AF:
0.00808
AC:
206
AN:
25486
American (AMR)
AF:
0.00436
AC:
68
AN:
15590
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19418
East Asian (EAS)
AF:
0.00136
AC:
38
AN:
28040
South Asian (SAS)
AF:
0.00531
AC:
237
AN:
44626
European-Finnish (FIN)
AF:
0.0000255
AC:
1
AN:
39152
Middle Eastern (MID)
AF:
0.000507
AC:
2
AN:
3942
European-Non Finnish (NFE)
AF:
0.000208
AC:
206
AN:
990746
Other (OTH)
AF:
0.00101
AC:
50
AN:
49306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.621
Heterozygous variant carriers
0
23
45
68
90
113
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00282
AC:
425
AN:
150480
Hom.:
0
Cov.:
32
AF XY:
0.00280
AC XY:
206
AN XY:
73466
show subpopulations
African (AFR)
AF:
0.00855
AC:
353
AN:
41300
American (AMR)
AF:
0.00232
AC:
35
AN:
15118
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3448
East Asian (EAS)
AF:
0.000394
AC:
2
AN:
5078
South Asian (SAS)
AF:
0.00187
AC:
9
AN:
4806
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10018
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000341
AC:
23
AN:
67418
Other (OTH)
AF:
0.00144
AC:
3
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
24
48
72
96
120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000111
Hom.:
0
Bravo
AF:
0.00306

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NRXN1: BS2 -

not specified Benign:1
Aug 11, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Sep 20, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

NRXN1-related disorder Benign:1
Oct 14, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.0
Mutation Taster
=197/3
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs750165040; hg19: chr2-50574008; API